Clorox Had a Great Quarter. Here's Why I'm Still Not Buying.
After a tough bout with inflation that wasn't fully paired with additional pricing power, The Clorox Company (NYSE: CLX) looks like it's finally on the mend. Earnings per share improved 48% from year-ago levels, boosted by (among other things) savvy cost-cutting. All of it prodded the stock 7% higher on Friday of last week to a new multi-month high.